Guerbet brings Vectorio to Canadian market

By AuntMinnieEurope.com staff writers

May 22, 2020 -- Contrast developer Guerbet has received approval to market its Vectorio contrast media kit in Canada for imaging of hepatocellular carcinoma (HCC).

A mixing and injection system for administering Guerbet's Lipiodol Ultra Fluid Injection, Vectorio facilitates imaging of liver tumors in adults with known HCC during interventional oncology procedures, according to the vendor.


Copyright © 2020 AuntMinnieEurope.com
 

To read this and get access to all of the exclusive content on AuntMinnieEurope.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnieEurope.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: